Skip to main content

You will need to login before you can apply for a job.

Senior Research Associate, Ocular Research

Entrada Therapeutics
Boston, MA
Start date
Jun 21, 2024

View more

Regulatory, Research/Documentation, Science/R&D, Research
Required Education
Bachelors Degree
Position Type
Full time

Job Details

The Organization

What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.

Our Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA-, antibody- and enzyme-based programs for the potential treatment of neuromuscular, ocular, metabolic and immunological diseases, among others.

Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45 and 50 skipping amenable. We have also partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families.

The Perfect Addition to Our Team

You are a versatile, self-motivated, and eager Senior Research Associate who is looking forward to rolling up your sleeves and contributing to all aspects of the ocular pipeline here at Entrada. You look forward to supporting efforts for testing EEV, antisense oligonucleotides, small interfering ribonucleic acids, and gene editing in vivo and in vitro. You are ready to partner with drug discovery scientists as we evaluate gene targeting modalities and carry out analytical assays for functional validation both in vitro and in vivo.

The Opportunity

The Senior Research Associate, Ocular will have the opportunity to be involved in several aspects of discovery biology work, including assisting with and performing ocular injections in vivo, tissue collection and processing, and analysis of samples from in vivo, ex vivo and in vitro studies. They will be an integral part of the Ocular team, supporting the development and expansion of Entrada’s Ocular portfolio.


•    Perform techniques like DNA/RNA/protein extraction, RT-PCR, RT-qPCR, ddPCR, western blot, tissue embedding, sectioning, immunostaining, and imaging. 
•    Maintain and culture cell lines in support to in vitro and ex vivo studies
•    Develop and execute cell-based or ex-vivo assays for validating biological activity of oligonucleotide therapeutics. 
•    Prepare SOPs and other reports and publications.
•    Collaborate with cross functional Discovery Teams to advance the pipeline and contribute to the completion of corporate goals.

The Necessities

At Entrada, our passion for science, our devotion to patients and our values drives our behavior:

  • Humanity - We genuinely care about patients and about one another.
  • Tenacity - We are relentless and persistent in the pursuit of developing therapies for patients.
  • Creativity - We are creative problem solvers.
  • Collaboration - We are more than the sum of our parts.
  • Curiosity - We have a growth mindset and push conventional thought and theory.

To thrive on our team, you will need to come with:

•    BS with 4+ years or MS with 2+ years of relevant experience.
•    Experience with handling rodents and perform tissue collection for in vivo studies.
•    Experience in the ocular space, including ocular injection, is strongly preferred.
•    Hands-on experience with in vitro assays including PCR, ddPCR, qPCR, Western blotting, and immunostaining.
•    Organized and focused on moving projects forward.
•    Desire to work in an innovative and collaborative environment pursuing high reward science.
•    Ability to juggle and prioritize multiple responsibilities, projects, and timelines.  #LI-DS1

The Perks

By becoming a team member here at Entrada, you’ll have access to competitive health, dental, and vision coverage, as well as life insurance, and short term and long-term disability insurance. We value work life balance, you'll benefit from discretionary time off, paternity leave, and an excellent 401(k) package. We also offer a generous transportation stipend to commute as you wish. Our location in the vibrant and growing Seaport District is close to all the best that the city of Boston has to offer.

Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.

Third Party Staffing Agencies

Entrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes.

Privacy Statement

Entrada Therapeutics, Inc. (the “Entrada,” “we,” “us,” or “our”) respects your privacy and we want you to be familiar with how we collect, use, share, or otherwise process, your Personal Information. Please reference our privacy statement here to understand how and when your data is being used.


Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicle (EEV™) therapeutics, to engage intracellular targets that have long been considered inaccessible and undruggable. The Company’s EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through its proprietary, highly versatile and modular EEV platform, Entrada is building a robust development portfolio of oligonucleotide-, antibody- and enzyme-based programs for the potential treatment of neuromuscular diseases, immunology, oncology and diseases of the central nervous system. The Company’s lead oligonucleotide programs include ENTR-601-44 targeting Duchenne muscular dystrophy (DMD) and ENTR-701 targeting myotonic dystrophy type 1 (DM1).

Stock Symbol: TRDA
Stock Exchange: NASDAQ



Company info
One Design Center Place Suite 17- 500

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert